Electroacupuntura para la prevención de miocardiopatías en intervenciones quirúrgicas de corazón

En la revista de la Sociedad de Cirugía de Tórax (Elsiever) del 2010 publicaron un estudio en el que se realizó tratamiento de electoacupuntura en los cinco días previos a la intervención, a pacientes con valvulopatías cardíacas, comparándolos con un grupo testigo. Los resultados son relevantes, obteniendo tanto una mejoría clínica como de los indicadores de laboratorio en el  sufrimiento del miocardio tras la re perfusión cardíaca. Un método tan sencillo y cada vez más predecible como es la acupuntura, irá ocupando paulatinamente un lugar más prominente dentro de las técnicas médicas habitulales.

A continuación el abstract de la publicación:

Ann Thorac Surg. 2010 Mar;89(3):781-6.

Cardioprotective effects of electroacupuncture pretreatment on patients undergoing heart valve replacement surgery: a randomized controlled trial.

Yang LYang JWang QChen MLu ZChen SXiong L.

Source

Department of Anesthesiology,XijingHospital,FourthMilitaryMedicalUniversity,Xi’an,China.

Abstract

BACKGROUND:

Cardiac ischemia-reperfusion injury after cardiopulmonary bypass contributes to postoperative morbidity and mortality in patients with open-heart surgery. This randomized controlled trial was designed to address the protective effects of electroacupuncture (EA) pretreatment on myocardial injury in patients undergoing heart valve replacement surgery.

METHODS:

Sixty patients with acquired heart valve disease were randomly allocated to the EA pretreatment group or the control group. Patients in the EA group received EA stimulus at bilateral Neiguan (PC 6), Lieque (LU 7), and Yunmen (LU 2) for 30 minutes each day for five consecutive days before surgery. Hemodynamic data, mechanical ventilation time, inotropic drug use in the intensive care unit, serum cardiac troponin I concentrations, morbidities, and mortalities were compared between the two groups. This trial is registered with ClinicalTrials.gov, number NCT00732459.

RESULTS:

At 6 hours, 12 hours, and 24 hours after reperfusion, levels of serum cardiac troponin I were significantly decreased in the EA group (5.74 +/- 0.67, 6.22 +/- 0.66, and 5.21 +/- 0.58) compared with that in the control group (7.89 +/- 0.74, 8.34 +/- 1.08, and 7.57 +/- 0.89, p < 0.05). The EA pretreatment significantly reduced overall serum troponin I release at 6 hours, 12 hours, and 24 hours after aortic cross-clamp removal. Meanwhile, EA pretreatment also reduced the inotrope score at 12 hours, 24 hours, and 48 hours after the intensive care unit arrival and shortened intensive care unit stay time (p < 0.05).

CONCLUSIONS:

The present study demonstrated that EA pretreatment may alleviate cardiac ischemia-reperfusion injury in adult patients undergoing heart valve replacements. This simple and convenient treatment has the potential to be used in the clinic for reducing myocardial injury in patients with heart valve replacement surgery.

2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s